```html

Yo‑Yo Disease (Rebound Obesity)

Overview

Yo‑yo disease, also called rebound obesity or “weight‑cycling,” describes the pattern of repeatedly losing weight through dieting and then regaining (often more) weight over time. Although “yo‑yo” is a lay term, the phenomenon is well‑documented in clinical research and is associated with metabolic, cardiovascular, and psychological consequences.

Who is affected? Yo‑yo dieting is most common among adults attempting rapid weight loss, especially women aged 30–55, but it also occurs in adolescents and older adults. A 2020 systematic review found that up to 45 % of people who dieted for ≥6 months experienced at least one episode of weight regain ≥10 % of their initial body weight within two years [1].

Prevalence: In the United States, about 30 % of adults have tried at least one “crash” diet in the past year, and among them, roughly one‑third report repeated cycles of loss and regain [2]. Similar trends are observed in Europe, Canada, and parts of Asia where dieting culture is strong.

Symptoms

The symptoms of yo‑yo disease are a mix of physical changes, metabolic signs, and psychological effects. They often overlap with those of obesity itself, but the cyclic nature adds distinctive features.

• Weight fluctuation – loss of ≥5 % of body weight followed by regain of ≥10 % within 12–24 months.
• Increased visceral (abdominal) fat – even if total weight returns to baseline, fat tends to shift toward the belly.
• Elevated fasting glucose & insulin resistance – labs may show higher HbA1c or HOMA‑IR scores despite a normal BMI.
• Altered lipid profile – higher triglycerides, lower HDL‑C.
• Higher resting heart rate & blood pressure – sympathovagal imbalance after repeated dieting.
• Fatigue & low energy – due to metabolic inefficiency and possible micronutrient deficits.
• Hormonal disturbances – decreased leptin and increased ghrelin, making hunger more intense.
• Psychological symptoms – anxiety about weight, body‑image dissatisfaction, binge‑eating episodes, and depressive moods.
• Reduced lean muscle mass – especially when weight loss relied on very low‑calorie diets without resistance training.
• Sleep disturbances – insomnia or sleep‑apnea worsening with each regain.

Causes and Risk Factors

Yo‑yo disease is not a single disease entity but a consequence of certain weight‑loss approaches combined with individual susceptibility.

Primary Causes

• Extreme calorie restriction – diets < 800 kcal/day or “quick‑fix” plans create rapid fat loss but also trigger metabolic slowdown.
• Very low‑protein diets – inadequate protein leads to loss of lean mass, which later contributes to faster regain.
• Lack of sustainable habits – relying on short‑term meal replacements, detox teas, or fad diets without behavior change.
• Psychological stress – stress‑induced cortisol spikes favor abdominal fat accumulation during regain.

Risk Factors

• History of dieting or previous weight‑loss attempts (the more cycles, the higher the risk).
• Female sex – hormonal variations may make women more prone to rebound weight gain.
• Age 25‑55 – metabolism naturally slows, making maintenance harder after loss.
• Genetic predisposition to obesity (e.g., FTO gene variants).
• Underlying endocrine disorders (hypothyroidism, polycystic ovary syndrome).
• Psychiatric conditions (binge‑eating disorder, depression, anxiety).
• Low socioeconomic status – limited access to affordable, healthy foods and safe places for exercise.

Diagnosis

Yo‑yo disease is diagnosed clinically; there is no single lab test. The assessment focuses on weight history, metabolic markers, and exclusion of other causes.

Clinical Evaluation

1. Detailed weight‑trajectory chart – patients plot weight (kg or lbs) over the prior 3‑5 years.
2. Dietary history – type, duration, and intensity of past diets.
3. Physical exam – waist circumference, BMI, and body‑composition analysis (e.g., bioelectrical impedance).
4. Psychological screening – using tools such as the PHQ‑9 or Binge Eating Scale.

Laboratory Tests

• Fasting glucose, HbA1c – assess glucose control.
• Lipid panel – triglycerides, HDL‑C, LDL‑C.
• Thyroid‑stimulating hormone (TSH) – rule out hypothyroidism.
• Insulin & C‑peptide – calculate HOMA‑IR for insulin resistance.
• Leptin & ghrelin (research setting) – may show dysregulation.

Imaging (if indicated)

• Abdominal ultrasound or MRI – evaluate visceral fat if cardiometabolic risk is high.
• DEXA scan – precise measurement of fat vs. lean mass.

Treatment Options

Treatment aims to break the cycle by restoring metabolic balance, building sustainable habits, and addressing psychological factors.

Lifestyle Interventions (First‑Line)

• Gradual, moderate calorie deficit – 500‑750 kcal/day below estimated maintenance, preserving protein (1.2‑1.5 g/kg body weight).
• Resistance training – 2‑3 times/week to maintain or increase lean muscle mass.
• Aerobic activity – 150 min/week of moderate‑intensity cardio (walking, cycling).
• Behavioral counseling – cognitive‑behavioral therapy (CBT) or “motivational interviewing” to develop coping skills.
• Structured meal planning – balanced meals with whole foods, fiber‑rich carbs, healthy fats, and portion control.

Pharmacotherapy

Medications are considered when lifestyle changes alone are insufficient and BMI ≥ 30 kg/m² (or ≥ 27 kg/m² with comorbidities).

Drug	Mechanism	Typical Use	Key Side Effects
Orlistat	Gastrointestinal lipase inhibitor	5 % additional weight loss	Steatorrhea, fat‑soluble vitamin deficiency
Liraglutide (3 mg)	GLP‑1 receptor agonist	Up to 8 % loss, improves glycemia	Nausea, pancreatitis risk
Phentermine‑topiramate	Appetite suppression + neurotransmitter modulation	7‑10 % loss	Dry mouth, insomnia, teratogenicity
Bupropion‑naltrexone	Dopamine‑noradrenaline & opioid antagonism	5‑6 % loss	BP elevation, seizure risk

All anti‑obesity drugs require a prescription, a baseline cardiovascular assessment, and periodic monitoring.

Procedural Options

• Bariatric surgery (gastric sleeve, Roux‑en‑Y gastric bypass) – considered for BMI ≥ 40 kg/m² or ≥ 35 kg/m² with serious comorbidities. Surgery provides the most durable weight loss and reduces yo‑yo cycles when combined with lifelong follow‑up.
• Endoscopic sleeve gastroplasty – less invasive alternative with ~15‑20 % excess weight loss at 2 years.

Psychological Support

CBT, dialectical‑behavior therapy (DBT), and support groups (e.g., Weight Watchers, Overeaters Anonymous) are effective in reducing binge episodes and improving adherence.

Living with Yo‑Yo Disease (Rebound Obesity)

Successful long‑term management hinges on daily habits that stabilize metabolism and prevent relapse.

Practical Daily Tips

• Eat protein at each meal – 20‑30 g helps preserve muscle and control hunger.
• Prioritize fiber – 25‑35 g/day (vegetables, legumes, whole grains) slows glucose absorption.
• Mindful eating – chew slowly, put utensils down between bites, and recognize satiety cues.
• Stay hydrated – 2‑3 L water/day; thirst is often misinterpreted as hunger.
• Schedule regular activity – set a calendar reminder for short walks or strength sessions.
• Sleep hygiene – aim for 7‑9 hours; insufficient sleep raises ghrelin.
• Stress management – meditation, yoga, or deep‑breathing reduces cortisol spikes.
• Track progress non‑scale – waist measurement, clothing fit, or fitness milestones.
• Periodic health check‑ups – labs every 6‑12 months to monitor glucose, lipids, and thyroid.

Technology Aids

Apps that log food intake (MyFitnessPal), activity (Fitbit, Apple Watch), and mood can provide feedback loops to catch early signs of a rebound.

Prevention

Preventing yo‑yo disease is easier than breaking it.

1. Adopt a modest, sustainable calorie reduction rather than “quick‑fix” diets.
2. Incorporate strength training early to protect lean mass.
3. Set realistic, non‑weight‑focused goals (e.g., improve blood pressure, increase stamina).
4. Seek professional guidance from a registered dietitian or certified health coach before starting any diet.
5. Address emotional eating with therapy or support groups before weight‑loss attempts.
6. Maintain regular medical screening for metabolic markers, especially if you have a family history of diabetes or heart disease.

Complications

If yo‑yo cycles continue unabated, the cumulative health burden can be substantial.

• Metabolic syndrome – higher risk of type‑2 diabetes, hypertension, dyslipidemia.
• Cardiovascular disease – increased arterial stiffness and atherosclerosis.
• Non‑alcoholic fatty liver disease (NAFLD) – progression to steatohepatitis.
• Reduced bone mineral density – especially with very low‑calorie diets lacking calcium and vitamin D.
• Psychiatric sequelae – chronic low self‑esteem, depression, and eating‑disorder development.
• Decreased reproductive health – menstrual irregularities in women and reduced testosterone in men.

When to Seek Emergency Care

Sources: 1. Hill JO et al. “Weight Cycling and Health.” *Obesity Reviews*. 2020;21(12):e13188. 2. CDC. “Adult Obesity Trends.” 2022. 3. Mayo Clinic. “Weight‑Loss Diets: Which One Is Right for You?” 2023. 4. NIH. “Guidelines for the Management of Overweight and Obesity in Adults.” 2021. 5. WHO. “Obesity and Overweight Fact Sheet.” 2022.

```